

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | humoral immune response (GO:0006959) | 9.47455521 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 8.03088269 |
| 3 | glomerular filtration (GO:0003094) | 6.60933278 |
| 4 | signal peptide processing (GO:0006465) | 6.21806729 |
| 5 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 6.12737722 |
| 6 | negative regulation of glucose import (GO:0046325) | 6.12384014 |
| 7 | renal filtration (GO:0097205) | 5.91508819 |
| 8 | regulation of respiratory burst (GO:0060263) | 5.60733123 |
| 9 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.29814163 |
| 10 | negative regulation of B cell proliferation (GO:0030889) | 5.11621955 |
| 11 | Fc-epsilon receptor signaling pathway (GO:0038095) | 5.02173566 |
| 12 | Fc receptor signaling pathway (GO:0038093) | 4.92472812 |
| 13 | negative regulation of glucose transport (GO:0010829) | 4.90486313 |
| 14 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.71566230 |
| 15 | phenylpropanoid metabolic process (GO:0009698) | 4.71356276 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 4.50464266 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.38462797 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.37443253 |
| 19 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.34629022 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.21857975 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.20127808 |
| 22 | detection of other organism (GO:0098543) | 4.19998989 |
| 23 | fucose catabolic process (GO:0019317) | 4.18212931 |
| 24 | L-fucose metabolic process (GO:0042354) | 4.18212931 |
| 25 | L-fucose catabolic process (GO:0042355) | 4.18212931 |
| 26 | detection of bacterium (GO:0016045) | 4.16869905 |
| 27 | regulation of antigen processing and presentation (GO:0002577) | 4.12539926 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 4.12042482 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90729496 |
| 30 | immune response-activating signal transduction (GO:0002757) | 3.83436281 |
| 31 | cellular response to zinc ion (GO:0071294) | 3.82401318 |
| 32 | regulation of B cell proliferation (GO:0030888) | 3.79023168 |
| 33 | chronic inflammatory response (GO:0002544) | 3.77522103 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.77166530 |
| 35 | germinal center formation (GO:0002467) | 3.61299049 |
| 36 | regulation of germinal center formation (GO:0002634) | 3.58146272 |
| 37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57564127 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57564127 |
| 39 | regulation of B cell differentiation (GO:0045577) | 3.51898811 |
| 40 | activation of immune response (GO:0002253) | 3.48189401 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.46711631 |
| 42 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43423284 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37095434 |
| 44 | detection of external biotic stimulus (GO:0098581) | 3.36977323 |
| 45 | proline biosynthetic process (GO:0006561) | 3.33657095 |
| 46 | protein-chromophore linkage (GO:0018298) | 3.33590651 |
| 47 | regulation of cellular extravasation (GO:0002691) | 3.32503279 |
| 48 | B cell mediated immunity (GO:0019724) | 3.30232956 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29778804 |
| 50 | production of molecular mediator of immune response (GO:0002440) | 3.25577524 |
| 51 | defense response to protozoan (GO:0042832) | 3.22675743 |
| 52 | response to interleukin-15 (GO:0070672) | 3.19982109 |
| 53 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.17128629 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16933241 |
| 55 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.16104208 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.15868380 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.15868380 |
| 58 | response to type I interferon (GO:0034340) | 3.15277206 |
| 59 | negative regulation of cell killing (GO:0031342) | 3.14829642 |
| 60 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.14829642 |
| 61 | positive regulation of macrophage cytokine production (GO:0060907) | 3.14197895 |
| 62 | keratinization (GO:0031424) | 3.10891561 |
| 63 | positive regulation of immunoglobulin production (GO:0002639) | 3.10733660 |
| 64 | superoxide anion generation (GO:0042554) | 3.01936269 |
| 65 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.00143360 |
| 66 | complement activation, classical pathway (GO:0006958) | 28.2629349 |
| 67 | complement activation (GO:0006956) | 21.6880425 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 2.99499842 |
| 69 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.99084683 |
| 70 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.97967532 |
| 71 | regulation of integrin activation (GO:0033623) | 2.91330512 |
| 72 | detection of biotic stimulus (GO:0009595) | 2.88100413 |
| 73 | wound healing, spreading of epidermal cells (GO:0035313) | 2.85549747 |
| 74 | positive regulation of type 2 immune response (GO:0002830) | 2.84279895 |
| 75 | cellular response to interleukin-15 (GO:0071350) | 2.82083358 |
| 76 | tissue homeostasis (GO:0001894) | 2.80854257 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 2.79279801 |
| 78 | negative regulation of B cell activation (GO:0050869) | 2.77502632 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.77147738 |
| 80 | negative thymic T cell selection (GO:0045060) | 2.77094498 |
| 81 | B cell proliferation (GO:0042100) | 2.77090728 |
| 82 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.74931781 |
| 83 | lymph node development (GO:0048535) | 2.74411763 |
| 84 | eosinophil chemotaxis (GO:0048245) | 2.74340408 |
| 85 | positive thymic T cell selection (GO:0045059) | 2.73297282 |
| 86 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72864937 |
| 87 | Golgi transport vesicle coating (GO:0048200) | 2.72734894 |
| 88 | COPI coating of Golgi vesicle (GO:0048205) | 2.72734894 |
| 89 | response to protozoan (GO:0001562) | 2.72268902 |
| 90 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71978640 |
| 91 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.71005177 |
| 92 | positive regulation of interferon-alpha production (GO:0032727) | 2.70160110 |
| 93 | peptidyl-asparagine modification (GO:0018196) | 2.69781692 |
| 94 | cellular response to interferon-gamma (GO:0071346) | 2.67553504 |
| 95 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.66730197 |
| 96 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.64061266 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63596162 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 2.63596162 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63596162 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 2.63596162 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63596162 |
| 102 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63596162 |
| 103 | xenobiotic catabolic process (GO:0042178) | 2.61015543 |
| 104 | B cell homeostasis (GO:0001782) | 2.60787510 |
| 105 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.60488697 |
| 106 | positive regulation of T cell migration (GO:2000406) | 2.59739030 |
| 107 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.58885415 |
| 108 | cellular extravasation (GO:0045123) | 2.58737253 |
| 109 | regulation of B cell activation (GO:0050864) | 2.58331209 |
| 110 | neutrophil activation (GO:0042119) | 2.57588702 |
| 111 | negative regulation of humoral immune response (GO:0002921) | 2.56361660 |
| 112 | eosinophil migration (GO:0072677) | 2.56222793 |
| 113 | maternal placenta development (GO:0001893) | 2.55535196 |
| 114 | polyketide metabolic process (GO:0030638) | 2.55292964 |
| 115 | doxorubicin metabolic process (GO:0044598) | 2.55292964 |
| 116 | daunorubicin metabolic process (GO:0044597) | 2.55292964 |
| 117 | T-helper 1 type immune response (GO:0042088) | 2.53325245 |
| 118 | protein N-linked glycosylation (GO:0006487) | 2.52112790 |
| 119 | respiratory burst (GO:0045730) | 2.51512495 |
| 120 | regulation of interferon-alpha production (GO:0032647) | 2.50504042 |
| 121 | detection of molecule of bacterial origin (GO:0032490) | 2.50438388 |
| 122 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.50361423 |
| 123 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.50076725 |
| 124 | negative T cell selection (GO:0043383) | 2.49709317 |
| 125 | response to interferon-gamma (GO:0034341) | 2.47031040 |
| 126 | positive regulation of lymphocyte migration (GO:2000403) | 2.45819118 |
| 127 | mast cell activation (GO:0045576) | 2.45505889 |
| 128 | antibacterial humoral response (GO:0019731) | 2.43058229 |
| 129 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.41931449 |
| 130 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.41772629 |
| 131 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.39080828 |
| 132 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.37990312 |
| 133 | positive regulation of nuclease activity (GO:0032075) | 2.36467205 |
| 134 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.35378655 |
| 135 | cellular response to unfolded protein (GO:0034620) | 2.33969150 |
| 136 | N-glycan processing (GO:0006491) | 2.32011070 |
| 137 | I-kappaB phosphorylation (GO:0007252) | 2.31902125 |
| 138 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.31137198 |
| 139 | positive regulation of Rap GTPase activity (GO:0032854) | 2.28067490 |
| 140 | antimicrobial humoral response (GO:0019730) | 2.27404159 |
| 141 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.24677066 |
| 142 | regulation of nuclease activity (GO:0032069) | 2.23620091 |
| 143 | regulation of immunoglobulin production (GO:0002637) | 2.23224872 |
| 144 | intestinal epithelial cell development (GO:0060576) | 2.20876797 |
| 145 | regulation of macrophage cytokine production (GO:0010935) | 2.20582889 |
| 146 | cofactor catabolic process (GO:0051187) | 2.20559567 |
| 147 | proline metabolic process (GO:0006560) | 2.20300681 |
| 148 | benzene-containing compound metabolic process (GO:0042537) | 2.17604659 |
| 149 | N-acetylneuraminate metabolic process (GO:0006054) | 2.16129513 |
| 150 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.15511416 |
| 151 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.14499837 |
| 152 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.14122125 |
| 153 | thymic T cell selection (GO:0045061) | 2.13968257 |
| 154 | protein maturation by protein folding (GO:0022417) | 2.13587444 |
| 155 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.13232912 |
| 156 | negative regulation of interleukin-10 production (GO:0032693) | 2.12358378 |
| 157 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.12203806 |
| 158 | regulation of B cell apoptotic process (GO:0002902) | 2.11918785 |
| 159 | ER-nucleus signaling pathway (GO:0006984) | 2.10654314 |
| 160 | cellular response to topologically incorrect protein (GO:0035967) | 2.09973362 |
| 161 | mannose metabolic process (GO:0006013) | 2.04407780 |
| 162 | defense response to Gram-negative bacterium (GO:0050829) | 2.03418485 |
| 163 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.03116490 |
| 164 | fucose metabolic process (GO:0006004) | 2.02342119 |
| 165 | bone resorption (GO:0045453) | 2.01963603 |
| 166 | aldehyde catabolic process (GO:0046185) | 2.01623187 |
| 167 | protein activation cascade (GO:0072376) | 14.1517732 |
| 168 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 11.7365168 |
| 169 | Fc-gamma receptor signaling pathway (GO:0038094) | 11.7365168 |
| 170 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 11.7365168 |
| 171 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 11.5956368 |
| 172 | retina homeostasis (GO:0001895) | 11.0731271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.59727202 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.47189905 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.25484174 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.84205615 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.46928423 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.14509000 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.65789176 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.52670001 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.44408723 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.43574909 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.42575260 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.35559182 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03606948 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.98548093 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90534196 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.88649020 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.75568105 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72122266 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64614654 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.39686811 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35808890 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35771045 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.26635881 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16101637 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16097921 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.08224612 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04967802 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.04838422 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.00582588 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97865877 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97670958 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.96595246 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93448608 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91468348 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88870125 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.86129125 |
| 37 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.75313594 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74717892 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73926619 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72728177 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.69416639 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69160492 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65927672 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63580868 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62498813 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55728755 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55268028 |
| 48 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.54403753 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54121106 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52933164 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.52832059 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49645288 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47145274 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46635314 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44391654 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42877542 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37982318 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37147211 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37026924 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33012657 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.30451989 |
| 62 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.30208707 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29693357 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29163087 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28688085 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26946480 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25994889 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25579936 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.25137750 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23291873 |
| 71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22787288 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22070791 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20055456 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19686293 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19561177 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18014465 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17507511 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17396116 |
| 79 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17395124 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16865941 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16345558 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15465570 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13947096 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13133398 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12235867 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11475357 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10418269 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08537762 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07879861 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.07816069 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05673801 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04383577 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04264997 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04182968 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03304759 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03218413 |
| 97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02492414 |
| 98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02130928 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99728727 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99607400 |
| 101 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98855648 |
| 102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98781212 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97820259 |
| 104 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97358084 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95986102 |
| 106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94844768 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91699025 |
| 108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91368814 |
| 109 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88689627 |
| 110 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88447141 |
| 111 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.88350360 |
| 112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87718176 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87276108 |
| 114 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.86538465 |
| 115 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86186526 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85987423 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85701795 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85639545 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85058886 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84669943 |
| 121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83713514 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83659376 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82326454 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81548968 |
| 125 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80986033 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80693183 |
| 127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78910914 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78349693 |
| 129 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78304250 |
| 130 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78285169 |
| 131 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78218438 |
| 132 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77283011 |
| 133 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76479019 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75832129 |
| 135 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75370981 |
| 136 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75293734 |
| 137 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75261424 |
| 138 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.75083741 |
| 139 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73552086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.28553883 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.17530254 |
| 3 | MP0001800_abnormal_humoral_immune | 4.45056215 |
| 4 | MP0003303_peritoneal_inflammation | 4.24378204 |
| 5 | MP0005671_abnormal_response_to | 3.56864822 |
| 6 | MP0005387_immune_system_phenotype | 3.17317349 |
| 7 | MP0001790_abnormal_immune_system | 3.17317349 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.12444660 |
| 9 | MP0006054_spinal_hemorrhage | 2.84902776 |
| 10 | MP0002723_abnormal_immune_serum | 2.72968390 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.53395177 |
| 12 | MP0001819_abnormal_immune_cell | 2.48704105 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.43669309 |
| 14 | MP0002398_abnormal_bone_marrow | 2.43059047 |
| 15 | MP0000716_abnormal_immune_system | 2.39390711 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.34523877 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.34522282 |
| 18 | MP0000685_abnormal_immune_system | 2.25826944 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.23822858 |
| 20 | MP0005166_decreased_susceptibility_to | 2.20428323 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.17647776 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.11689741 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.05042149 |
| 24 | MP0005025_abnormal_response_to | 1.99834120 |
| 25 | MP0005360_urolithiasis | 1.99530115 |
| 26 | MP0005275_abnormal_skin_tensile | 1.98991429 |
| 27 | MP0002429_abnormal_blood_cell | 1.94314250 |
| 28 | MP0008004_abnormal_stomach_pH | 1.93789408 |
| 29 | MP0001879_abnormal_lymphatic_vessel | 1.92427340 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.89275077 |
| 31 | MP0002006_tumorigenesis | 1.88934218 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.87304251 |
| 33 | MP0002419_abnormal_innate_immunity | 1.81121684 |
| 34 | MP0004947_skin_inflammation | 1.76409947 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.74021029 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.72537144 |
| 37 | MP0002722_abnormal_immune_system | 1.68277278 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.64713901 |
| 39 | MP0003436_decreased_susceptibility_to | 1.61049431 |
| 40 | MP0004782_abnormal_surfactant_physiolog | 1.60483877 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.58092860 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.54565493 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.52704045 |
| 44 | MP0000920_abnormal_myelination | 1.52379808 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.50335280 |
| 46 | MP0009764_decreased_sensitivity_to | 1.50074469 |
| 47 | MP0004859_abnormal_synaptic_plasticity | 1.42701207 |
| 48 | MP0002405_respiratory_system_inflammati | 1.35748776 |
| 49 | MP0002796_impaired_skin_barrier | 1.35310636 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.34729625 |
| 51 | MP0000343_altered_response_to | 1.34129993 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.32222795 |
| 53 | MP0001851_eye_inflammation | 1.30205563 |
| 54 | MP0009046_muscle_twitch | 1.29795649 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.29290025 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.28644875 |
| 57 | MP0008569_lethality_at_weaning | 1.25366025 |
| 58 | MP0006082_CNS_inflammation | 1.24748647 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.23264804 |
| 60 | MP0003045_fibrosis | 1.23256946 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.22424567 |
| 62 | MP0003828_pulmonary_edema | 1.18115328 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.17205643 |
| 64 | MP0005310_abnormal_salivary_gland | 1.17007872 |
| 65 | MP0003075_altered_response_to | 1.16750996 |
| 66 | MP0009785_altered_susceptibility_to | 1.16441909 |
| 67 | MP0003448_altered_tumor_morphology | 1.13655320 |
| 68 | MP0009278_abnormal_bone_marrow | 1.11511220 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.10863330 |
| 70 | MP0005623_abnormal_meninges_morphology | 1.10600128 |
| 71 | MP0005164_abnormal_response_to | 1.10055369 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.09369437 |
| 73 | MP0004858_abnormal_nervous_system | 1.07867740 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.06744999 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 1.06744999 |
| 76 | MP0001849_ear_inflammation | 1.06299788 |
| 77 | MP0001853_heart_inflammation | 1.04503518 |
| 78 | MP0005390_skeleton_phenotype | 1.00919262 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00655207 |
| 80 | MP0008872_abnormal_physiological_respon | 1.00174632 |
| 81 | MP0003279_aneurysm | 0.99821813 |
| 82 | MP0003690_abnormal_glial_cell | 0.99727382 |
| 83 | MP0000858_altered_metastatic_potential | 0.98685538 |
| 84 | MP0000249_abnormal_blood_vessel | 0.98428793 |
| 85 | MP0003866_abnormal_defecation | 0.98337656 |
| 86 | MP0005332_abnormal_amino_acid | 0.97725538 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.97122285 |
| 88 | MP0005083_abnormal_biliary_tract | 0.96325238 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.96059377 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.95039506 |
| 91 | MP0004510_myositis | 0.93318582 |
| 92 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92945519 |
| 93 | MP0003186_abnormal_redox_activity | 0.91502819 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.90538037 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.89673938 |
| 96 | MP0000609_abnormal_liver_physiology | 0.88383009 |
| 97 | MP0002933_joint_inflammation | 0.88344490 |
| 98 | MP0003880_abnormal_central_pattern | 0.87930517 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.87199032 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.86272032 |
| 101 | MP0005365_abnormal_bile_salt | 0.85608709 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.85351939 |
| 103 | MP0001873_stomach_inflammation | 0.85108186 |
| 104 | MP0003252_abnormal_bile_duct | 0.83849540 |
| 105 | MP0008469_abnormal_protein_level | 0.83007969 |
| 106 | MP0000490_abnormal_crypts_of | 0.82603555 |
| 107 | MP0002133_abnormal_respiratory_system | 0.82145071 |
| 108 | MP0005388_respiratory_system_phenotype | 0.82145071 |
| 109 | MP0005451_abnormal_body_composition | 0.81863781 |
| 110 | MP0001919_abnormal_reproductive_system | 0.80270353 |
| 111 | MP0000604_amyloidosis | 0.79453320 |
| 112 | MP0001666_abnormal_nutrient_absorption | 0.79269469 |
| 113 | MP0002254_reproductive_system_inflammat | 0.76954334 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.76123481 |
| 115 | MP0010329_abnormal_lipoprotein_level | 0.73725265 |
| 116 | MP0001663_abnormal_digestive_system | 0.71463603 |
| 117 | MP0003879_abnormal_hair_cell | 0.71450205 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.69510172 |
| 119 | MP0008057_abnormal_DNA_replication | 0.69309994 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.69177749 |
| 121 | MP0008874_decreased_physiological_sensi | 0.68446401 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.67971470 |
| 123 | MP0002873_normal_phenotype | 0.67785117 |
| 124 | MP0002169_no_abnormal_phenotype | 0.67480820 |
| 125 | MP0003329_amyloid_beta_deposits | 0.66944993 |
| 126 | MP0001348_abnormal_lacrimal_gland | 0.66219856 |
| 127 | MP0010368_abnormal_lymphatic_system | 0.65851684 |
| 128 | MP0003868_abnormal_feces_composition | 0.65704879 |
| 129 | MP0002083_premature_death | 0.64786730 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.64770554 |
| 131 | MP0001958_emphysema | 0.64250351 |
| 132 | MP0004084_abnormal_cardiac_muscle | 0.64190052 |
| 133 | MP0000003_abnormal_adipose_tissue | 0.63788851 |
| 134 | MP0003806_abnormal_nucleotide_metabolis | 0.61102876 |
| 135 | MP0003633_abnormal_nervous_system | 0.60609974 |
| 136 | MP0004885_abnormal_endolymph | 0.60089352 |
| 137 | MP0009763_increased_sensitivity_to | 0.59315035 |
| 138 | MP0004142_abnormal_muscle_tone | 0.58066949 |
| 139 | MP0001542_abnormal_bone_strength | 0.57950892 |
| 140 | MP0009765_abnormal_xenobiotic_induced | 0.57851843 |
| 141 | MP0003795_abnormal_bone_structure | 0.57414575 |
| 142 | MP0005503_abnormal_tendon_morphology | 0.56902623 |
| 143 | MP0005023_abnormal_wound_healing | 0.56466725 |
| 144 | MP0002060_abnormal_skin_morphology | 0.56119798 |
| 145 | MP0004883_abnormal_blood_vessel | 0.55452772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 8.37679841 |
| 2 | Abnormality of B cell number (HP:0010975) | 8.37679841 |
| 3 | Agammaglobulinemia (HP:0004432) | 8.31261775 |
| 4 | Prostate neoplasm (HP:0100787) | 7.92022327 |
| 5 | Abnormality of macrophages (HP:0004311) | 6.66497535 |
| 6 | Recurrent bronchitis (HP:0002837) | 6.10890365 |
| 7 | Recurrent sinusitis (HP:0011108) | 6.10333378 |
| 8 | Cellulitis (HP:0100658) | 5.75444382 |
| 9 | Abnormality of the prostate (HP:0008775) | 5.47818412 |
| 10 | Papilloma (HP:0012740) | 5.31935785 |
| 11 | Verrucae (HP:0200043) | 5.31935785 |
| 12 | Colitis (HP:0002583) | 5.20572343 |
| 13 | IgM deficiency (HP:0002850) | 4.96807736 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 4.77597951 |
| 15 | Recurrent viral infections (HP:0004429) | 4.65975753 |
| 16 | Meningitis (HP:0001287) | 4.44044173 |
| 17 | Recurrent pneumonia (HP:0006532) | 4.36410034 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 4.06230307 |
| 19 | Increased IgE level (HP:0003212) | 4.02890966 |
| 20 | Thyroiditis (HP:0100646) | 3.99108315 |
| 21 | Leukocytosis (HP:0001974) | 3.83658850 |
| 22 | Chronic otitis media (HP:0000389) | 3.81891290 |
| 23 | Chronic sinusitis (HP:0011109) | 3.81232938 |
| 24 | Inflammation of the large intestine (HP:0002037) | 3.60691745 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.46012977 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45620554 |
| 27 | Obstructive lung disease (HP:0006536) | 3.45620554 |
| 28 | Osteomyelitis (HP:0002754) | 3.43689376 |
| 29 | Recurrent otitis media (HP:0000403) | 3.43333254 |
| 30 | Recurrent lower respiratory tract infections (HP:0002783) | 3.41306717 |
| 31 | Bronchitis (HP:0012387) | 3.39084623 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.34042376 |
| 33 | IgG deficiency (HP:0004315) | 3.33684351 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.21452547 |
| 35 | Abnormality of male internal genitalia (HP:0000022) | 3.19249944 |
| 36 | Sepsis (HP:0100806) | 3.16314301 |
| 37 | Urticaria (HP:0001025) | 3.11447873 |
| 38 | Hypoplasia of the thymus (HP:0000778) | 2.99372964 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.95292176 |
| 40 | Skin rash (HP:0000988) | 2.91344596 |
| 41 | Cervical subluxation (HP:0003308) | 2.89723747 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.89245178 |
| 43 | Neoplasm of the lung (HP:0100526) | 2.87084894 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.85981656 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81133688 |
| 46 | Hematochezia (HP:0002573) | 2.76317268 |
| 47 | Emphysema (HP:0002097) | 2.75656155 |
| 48 | IgA deficiency (HP:0002720) | 2.74629710 |
| 49 | T lymphocytopenia (HP:0005403) | 2.71490024 |
| 50 | Abnormality of T cells (HP:0002843) | 2.70939448 |
| 51 | Orchitis (HP:0100796) | 2.69383291 |
| 52 | Gingivitis (HP:0000230) | 2.68023084 |
| 53 | Mitral stenosis (HP:0001718) | 2.66308866 |
| 54 | Vasculitis (HP:0002633) | 2.55712245 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.54008303 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.52741328 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.50015589 |
| 58 | Increased IgM level (HP:0003496) | 2.49236500 |
| 59 | Neoplasm of the respiratory system (HP:0100606) | 2.47222232 |
| 60 | Hemoptysis (HP:0002105) | 2.45783455 |
| 61 | Dehydration (HP:0001944) | 2.45480434 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.44735076 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.41132843 |
| 64 | Optic neuritis (HP:0100653) | 2.41132843 |
| 65 | Hypermelanotic macule (HP:0001034) | 2.39510519 |
| 66 | Combined immunodeficiency (HP:0005387) | 2.37615519 |
| 67 | Severe combined immunodeficiency (HP:0004430) | 2.36310067 |
| 68 | Restrictive lung disease (HP:0002091) | 2.34318972 |
| 69 | Glomerulonephritis (HP:0000099) | 2.33754274 |
| 70 | Myositis (HP:0100614) | 2.31528396 |
| 71 | Abnormality of the peritoneum (HP:0002585) | 2.31337315 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 2.29622439 |
| 73 | Mucosal telangiectasiae (HP:0100579) | 2.29540422 |
| 74 | Recurrent abscess formation (HP:0002722) | 2.28699537 |
| 75 | Gangrene (HP:0100758) | 2.27487438 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.25604391 |
| 77 | Acrocyanosis (HP:0001063) | 2.23827578 |
| 78 | Recurrent bacterial skin infections (HP:0005406) | 2.23473821 |
| 79 | Alopecia of scalp (HP:0002293) | 2.20386810 |
| 80 | Hyperactive renin-angiotensin system (HP:0000841) | 2.20008967 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 2.19905082 |
| 82 | Malnutrition (HP:0004395) | 2.18052998 |
| 83 | Abnormality of complement system (HP:0005339) | 2.17284803 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.16835470 |
| 85 | Granulocytopenia (HP:0001913) | 2.16070429 |
| 86 | Abnormality of nail color (HP:0100643) | 2.15514980 |
| 87 | Nephritis (HP:0000123) | 2.14550404 |
| 88 | Xerostomia (HP:0000217) | 2.13960246 |
| 89 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13372368 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.10798065 |
| 91 | Premature loss of primary teeth (HP:0006323) | 2.08476706 |
| 92 | Pulmonary infiltrates (HP:0002113) | 2.07858383 |
| 93 | Pustule (HP:0200039) | 2.03710309 |
| 94 | Skin ulcer (HP:0200042) | 2.03187938 |
| 95 | Hypoproteinemia (HP:0003075) | 2.03059765 |
| 96 | J-shaped sella turcica (HP:0002680) | 2.02119557 |
| 97 | Lymphopenia (HP:0001888) | 2.02070935 |
| 98 | Hypertensive crisis (HP:0100735) | 2.01230844 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99475811 |
| 100 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98010407 |
| 101 | Complement deficiency (HP:0004431) | 1.97511242 |
| 102 | Gingival bleeding (HP:0000225) | 1.97250943 |
| 103 | Thick nail (HP:0001805) | 1.95815551 |
| 104 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94117204 |
| 105 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94117204 |
| 106 | Nonimmune hydrops fetalis (HP:0001790) | 1.93194368 |
| 107 | Encephalitis (HP:0002383) | 1.92732711 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91647791 |
| 109 | Recurrent skin infections (HP:0001581) | 1.90107669 |
| 110 | Polycythemia (HP:0001901) | 1.88917282 |
| 111 | Colon cancer (HP:0003003) | 1.87498751 |
| 112 | Macroorchidism (HP:0000053) | 1.87401519 |
| 113 | Eosinophilia (HP:0001880) | 1.87365664 |
| 114 | Abnormality of the pleura (HP:0002103) | 1.86803039 |
| 115 | Abnormal gallbladder morphology (HP:0012437) | 1.86301657 |
| 116 | Stomatitis (HP:0010280) | 1.85444216 |
| 117 | Cholelithiasis (HP:0001081) | 1.84965231 |
| 118 | Nasal polyposis (HP:0100582) | 1.84825251 |
| 119 | Neutropenia (HP:0001875) | 1.76954881 |
| 120 | Keratoconjunctivitis sicca (HP:0001097) | 1.76932093 |
| 121 | Arthralgia (HP:0002829) | 1.76250694 |
| 122 | Conjunctival hamartoma (HP:0100780) | 1.73713092 |
| 123 | Acute encephalopathy (HP:0006846) | 1.72456795 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 1.70827202 |
| 125 | Dysostosis multiplex (HP:0000943) | 1.70166859 |
| 126 | Papilledema (HP:0001085) | 1.69692508 |
| 127 | Hyperventilation (HP:0002883) | 1.68953962 |
| 128 | Progressive macrocephaly (HP:0004481) | 1.67036776 |
| 129 | Keratoconjunctivitis (HP:0001096) | 1.66436636 |
| 130 | Bronchiectasis (HP:0002110) | 1.64458611 |
| 131 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.64318474 |
| 132 | Exercise-induced myalgia (HP:0003738) | 1.62149673 |
| 133 | Teleangiectasia of the skin (HP:0100585) | 1.62100353 |
| 134 | Thrombocytosis (HP:0001894) | 1.61335623 |
| 135 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.58805786 |
| 136 | Hyperbilirubinemia (HP:0002904) | 1.58567759 |
| 137 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.57868423 |
| 138 | Limb hypertonia (HP:0002509) | 1.57623143 |
| 139 | Eczematoid dermatitis (HP:0000976) | 1.56601540 |
| 140 | Acute necrotizing encephalopathy (HP:0006965) | 1.56115447 |
| 141 | Camptodactyly of toe (HP:0001836) | 1.53961481 |
| 142 | Supranuclear gaze palsy (HP:0000605) | 1.53296216 |
| 143 | Lymphoma (HP:0002665) | 1.52783950 |
| 144 | Intrahepatic cholestasis (HP:0001406) | 1.52151465 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.51776027 |
| 146 | Xanthomatosis (HP:0000991) | 1.50251989 |
| 147 | Abnormality of eosinophils (HP:0001879) | 1.49034906 |
| 148 | Leukopenia (HP:0001882) | 1.46616811 |
| 149 | Hypergammaglobulinemia (HP:0010702) | 1.44818195 |
| 150 | Leukodystrophy (HP:0002415) | 1.44314336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.33152817 |
| 2 | MAP4K1 | 4.41878677 |
| 3 | RIPK4 | 3.03141979 |
| 4 | GRK6 | 2.75005811 |
| 5 | PDK2 | 2.56204554 |
| 6 | MST1R | 2.50899828 |
| 7 | TXK | 2.35786201 |
| 8 | SYK | 2.35695589 |
| 9 | SIK2 | 2.23156781 |
| 10 | KIT | 2.21188409 |
| 11 | ZAP70 | 2.16277246 |
| 12 | TYK2 | 2.15260139 |
| 13 | PIK3CA | 2.06793247 |
| 14 | BCKDK | 2.06352022 |
| 15 | CSF1R | 1.96601383 |
| 16 | MAP3K13 | 1.93732232 |
| 17 | MAP3K14 | 1.88444032 |
| 18 | RIPK1 | 1.86308216 |
| 19 | MAP3K10 | 1.83865656 |
| 20 | IRAK4 | 1.81136883 |
| 21 | BUB1 | 1.75061774 |
| 22 | MAP3K4 | 1.71011276 |
| 23 | TAOK3 | 1.69450469 |
| 24 | PRKCH | 1.68440736 |
| 25 | FES | 1.67253497 |
| 26 | LYN | 1.66708387 |
| 27 | EPHA3 | 1.65528212 |
| 28 | NME2 | 1.64654847 |
| 29 | BTK | 1.61476519 |
| 30 | TBK1 | 1.59668946 |
| 31 | ITK | 1.52399459 |
| 32 | PRPF4B | 1.50846216 |
| 33 | PIK3CG | 1.50796681 |
| 34 | EPHB1 | 1.45040037 |
| 35 | EIF2AK3 | 1.44748994 |
| 36 | BLK | 1.44227034 |
| 37 | MAP3K3 | 1.42483494 |
| 38 | CLK1 | 1.36462275 |
| 39 | IRAK3 | 1.35902694 |
| 40 | NEK2 | 1.34684052 |
| 41 | FRK | 1.33431641 |
| 42 | FGFR3 | 1.32863435 |
| 43 | FGFR2 | 1.31973457 |
| 44 | MAP3K1 | 1.29708601 |
| 45 | BMX | 1.27794291 |
| 46 | JAK1 | 1.25992100 |
| 47 | TAOK1 | 1.24746389 |
| 48 | BMPR2 | 1.24110808 |
| 49 | SIK1 | 1.21788427 |
| 50 | MAP2K3 | 1.19748175 |
| 51 | HCK | 1.19616371 |
| 52 | HIPK2 | 1.18382983 |
| 53 | MST4 | 1.15719726 |
| 54 | IRAK1 | 1.13144397 |
| 55 | STK10 | 1.12835564 |
| 56 | TTN | 1.08829924 |
| 57 | PRKCQ | 1.02390879 |
| 58 | UHMK1 | 1.01825477 |
| 59 | PIM1 | 1.01055050 |
| 60 | KDR | 1.00369610 |
| 61 | FGFR4 | 0.97796106 |
| 62 | FER | 0.93626618 |
| 63 | KSR2 | 0.91031105 |
| 64 | TGFBR2 | 0.88333522 |
| 65 | MAP3K9 | 0.87340467 |
| 66 | LCK | 0.86948275 |
| 67 | MATK | 0.84276024 |
| 68 | TAOK2 | 0.83958727 |
| 69 | NEK1 | 0.81645691 |
| 70 | IKBKB | 0.79261439 |
| 71 | PRKD1 | 0.79256324 |
| 72 | JAK3 | 0.75193243 |
| 73 | EEF2K | 0.74802422 |
| 74 | FYN | 0.72196420 |
| 75 | ALK | 0.71892294 |
| 76 | PKN1 | 0.70599285 |
| 77 | PKN2 | 0.69465042 |
| 78 | IKBKE | 0.67888648 |
| 79 | PDGFRA | 0.67338284 |
| 80 | LRRK2 | 0.66746118 |
| 81 | MAP3K5 | 0.64870222 |
| 82 | MAP3K11 | 0.64470463 |
| 83 | PRKD2 | 0.64332593 |
| 84 | MET | 0.63462338 |
| 85 | NTRK3 | 0.62433760 |
| 86 | CSK | 0.59682548 |
| 87 | DMPK | 0.58900842 |
| 88 | BRSK1 | 0.58272171 |
| 89 | PRKCD | 0.57810725 |
| 90 | CSNK1G3 | 0.57501542 |
| 91 | MAPK12 | 0.56687084 |
| 92 | CSNK1A1L | 0.55157358 |
| 93 | NLK | 0.54574882 |
| 94 | JAK2 | 0.54407073 |
| 95 | FGR | 0.54345140 |
| 96 | TESK2 | 0.54090879 |
| 97 | ADRBK2 | 0.53597980 |
| 98 | PDPK1 | 0.53545273 |
| 99 | NEK9 | 0.52921344 |
| 100 | MAPK4 | 0.51152138 |
| 101 | NEK6 | 0.50723007 |
| 102 | GRK1 | 0.50310910 |
| 103 | MAPKAPK3 | 0.50062132 |
| 104 | IGF1R | 0.49966401 |
| 105 | ARAF | 0.49212853 |
| 106 | DDR2 | 0.49018226 |
| 107 | CSNK1G2 | 0.48995903 |
| 108 | EPHA4 | 0.45683367 |
| 109 | TEC | 0.45204834 |
| 110 | RET | 0.44997833 |
| 111 | CAMKK1 | 0.42676960 |
| 112 | NME1 | 0.42429183 |
| 113 | YES1 | 0.41636459 |
| 114 | RPS6KA6 | 0.40995640 |
| 115 | MARK3 | 0.39009147 |
| 116 | PDGFRB | 0.38312121 |
| 117 | RPS6KL1 | 0.36781747 |
| 118 | RPS6KC1 | 0.36781747 |
| 119 | EPHA2 | 0.35918675 |
| 120 | STK24 | 0.35501887 |
| 121 | TIE1 | 0.34521634 |
| 122 | SIK3 | 0.34273787 |
| 123 | CDK5 | 0.32741066 |
| 124 | IRAK2 | 0.32312651 |
| 125 | MAPKAPK2 | 0.31542513 |
| 126 | INSR | 0.31279989 |
| 127 | ROCK2 | 0.31245651 |
| 128 | PDK1 | 0.30871207 |
| 129 | RPS6KB2 | 0.30801602 |
| 130 | CDK15 | 0.30535082 |
| 131 | MAPK7 | 0.30479561 |
| 132 | CDC42BPA | 0.29546268 |
| 133 | TGFBR1 | 0.29509343 |
| 134 | GRK5 | 0.28572848 |
| 135 | MYLK | 0.28494388 |
| 136 | ABL1 | 0.28396505 |
| 137 | ICK | 0.28223235 |
| 138 | MAP3K8 | 0.28002333 |
| 139 | ADRBK1 | 0.27934303 |
| 140 | EPHB2 | 0.27297027 |
| 141 | MAPK11 | 0.27206794 |
| 142 | FLT3 | 0.26352945 |
| 143 | LMTK2 | 0.25202452 |
| 144 | CHUK | 0.24794405 |
| 145 | CSNK1G1 | 0.24548512 |
| 146 | CDK18 | 0.24109635 |
| 147 | SRC | 0.23682334 |
| 148 | MAPK3 | 0.23258494 |
| 149 | PRKACB | 0.22906701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 9.07361855 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.75874026 |
| 3 | Protein export_Homo sapiens_hsa03060 | 4.60332273 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.33407229 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.13041069 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78140788 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.44333855 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.33913792 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00589395 |
| 10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.98169247 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.75734145 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.54124980 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49722725 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 1.48516634 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42635474 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33966677 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.32027254 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29316136 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.26478207 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26291027 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24485076 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23922793 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23865659 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22268671 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20985767 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16755726 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15618514 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14063424 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11400353 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11345201 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08342698 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07942973 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06971977 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05640924 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.01156662 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99467138 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98301509 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97702474 |
| 39 | Proteasome_Homo sapiens_hsa03050 | 0.94935332 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94789647 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94600064 |
| 42 | Malaria_Homo sapiens_hsa05144 | 0.93700823 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89712136 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84439305 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84344454 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84298446 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.84106932 |
| 48 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83399612 |
| 49 | DNA replication_Homo sapiens_hsa03030 | 0.82240447 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.81903581 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80482919 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78987605 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78715008 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78310332 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 0.74157424 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72281779 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71474206 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71468501 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.70347625 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69876775 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69405737 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68167197 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67905036 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67486367 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67065458 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.66555247 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64989740 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.64898694 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64279486 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63345093 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.62713935 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61322201 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57057632 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.56268942 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55759216 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55196035 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54916262 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54229684 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52440211 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52215995 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.50802011 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50409990 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49036688 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48069484 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47731711 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47692863 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47013067 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46712860 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46317130 |
| 90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46269368 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46025366 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45235722 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43573790 |
| 94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.43163867 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42414069 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42322335 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38644294 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38314324 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38079905 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36020342 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35818721 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.35793500 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.34658436 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.33492299 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33358108 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32886999 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32777179 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32731842 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32521511 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32300513 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32138625 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32018968 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31802876 |
| 114 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31738894 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31726114 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31192206 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30896864 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.30875010 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30231012 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29913963 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29687119 |
| 122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29578877 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29539258 |
| 124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.28342158 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27897309 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26798000 |
| 127 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26575918 |
| 128 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26548663 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26145994 |
| 130 | Legionellosis_Homo sapiens_hsa05134 | 0.25337309 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25215855 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24472753 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24390954 |
| 134 | Insulin secretion_Homo sapiens_hsa04911 | 0.24133293 |
| 135 | Platelet activation_Homo sapiens_hsa04611 | 0.24123391 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23834956 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23464934 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23424284 |
| 139 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.23221877 |
| 140 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.23201338 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.23159025 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23068321 |
| 143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.20878951 |
| 144 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20602741 |
| 145 | Carbon metabolism_Homo sapiens_hsa01200 | 0.19999491 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19350175 |
| 147 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19288352 |
| 148 | Hepatitis B_Homo sapiens_hsa05161 | 0.18411380 |
| 149 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18060561 |
| 150 | Measles_Homo sapiens_hsa05162 | 0.17749871 |
| 151 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17255011 |

